Baltimore said the new $45 million dealAllergan struck with the city to settle opioid claims validated its decision not to participate in the global settlement joined by thousands of other local governments and states.
Baltimore, whose devastation by the opioid epidemic has been spotlighted by the New York Times in recent weeks, said it would have received just $7 million over 7 years if it had joined the global settlement.
Instead, Baltimore said it's getting more than the $38 million Maryland is receiving from the company — and it will immediately get the money as a lump sum.
What's next: Baltimore said its remaining opioid lawsuits are with companies responsible for the vast majority of prescription painkillers in the city's pharmacies.
